Navigating the Pharmaceutical Packaging Market: Challenges, Innovations, and Future Outlook

• Amcor plc (Switzerland)
• AptarGroup, Inc. (U.S.)
• Becton, Dickinson and Company (U.S.)
• Gerresheimer AG (Germany)
• Schott Pharma AG & Co. KGaA (Germany)
• Berry Global Group, Inc. (U.S.)
• Drug Plastics Group (U.S.)
• Catalent, Inc. (U.S.)
• SGD Pharma (France)
• Corning Inc. (U.S.)
• WestRock Company (U.S.)
• West Pharmaceutical Services, Inc. (U.S.)

1. Material: This includes polymers (such as Polyvinyl Chloride, Polyethylene Terephthalate, Polypropylene, and others), glass, paper and paperboard, metal, and other materials. Among these, the glass segment is anticipated to exhibit the highest CAGR during the forecast period due to increased utilization in packaging, particularly for vials and ampoules.
2. Packaging Type: The market is categorized into primary packaging (which includes blister packs, bottles, vials, and others), secondary packaging, and tertiary packaging. The primary packaging segment is projected to hold the largest market share in 2024, driven by advancements in manufacturing technologies and increased R&D spending.
3. Dosage Form: This includes oral dosage forms (solid and liquid), parenteral dosage forms, and others. The parenteral dosage form segment is expected to demonstrate the highest growth rate, primarily due to its significance in the delivery of new molecular entities approved by regulatory agencies such as the U.S. FDA.
4. End User: The market is further segmented into pharmaceutical companies, contract packaging companies, and pharmacies. The pharmaceutical companies segment is projected to dominate the market in 2024, driven by increasing demand for medicines, particularly in light of the aging population and the rising incidence of chronic diseases.

• North America (U.S., Canada)
• Europe (Germany, France, U.K., and others)
• Asia-Pacific (China, India, Japan, and others)
• Latin America (Brazil, Mexico)
• Middle East & Africa